Top segments and regional performance

Last year, the company generated ‪48.59 B‬ INR, the most of which — ‪48.59 B‬ INR — came from its top-performing segment, Pharmaceutical, compared to ‪45.65 B‬ INR the previous year. The greatest contribution came from North America, which accounted for ‪24.89 B‬ INR last year, with ‪24.51 B‬ INR the year before.